申请人:Zhejiang Yangshengtang Institute
Of Natural Medication Co., Ltd.
公开号:EP3666267A1
公开(公告)日:2020-06-17
The present invention relates to a combination product comprising a limonoid compound (or a pharmaceutically acceptable derivative, ester, stereoisomer, salt or prodrug thereof), and a biguanide compound (e.g., metformin, metformin hydrochloride, buformin, and phenformin). The present invention further relates to a use of the combination product for prevention and/or treatment of a disease associated with diabetes, for lipid-lowering and weight-loss, and the like.
本发明涉及一种复方制剂,包括一种柠檬酸类化合物(或其药学上可接受的衍生物、酯、立体异构体、盐或原药)和一种双胍类化合物(如二甲双胍、盐酸二甲双胍、布福明和苯福明)。本发明进一步涉及组合产品在预防和/或治疗糖尿病相关疾病、降脂减肥等方面的用途。